Discontinuation of the manufacture of the drug. Product expected to be available through September 2026.

Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

Synagis, Injection, 50 mg/.5 mL (NDC 66658-230-01)


Pravastatin Sodium, Tablet, 80 mg (NDC 0480-7270-10)


Discontinuation of the manufacture of the drug product

Tazverik, Tablet, 200 mg (NDC 72607-100-00)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 4% 10X5ML)  is Preservative free.

Lidocaine Hydrochloride, Injection, 40 mg/1 mL (NDC 83090-007-10)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)


Discontinuation of the manufacture of the drug

Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)


Check wholesalers for inventory; Marketed by Fresenius Kabi 800-551-7176

Etomidate, Injection, 2 mg/mL (NDC 65219-447-20)


On backorder. Recovery: TBD. Check wholesalers for inventory

INTRA-ARTICULAR
INTRALESIONAL
INTRAMUSCULAR
SOFT TISSUE

Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE

AMPHETAMINE ASPARTATE MONOHYDRATE
AMPHETAMINE SULFATE
DEXTROAMPHETAMINE SACCHARATE
DEXTROAMPHETAMINE SULFATE

Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)


Rifampin, Injection, 600 mg (NDC 63323-351-20)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)


Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28)


Next release May 2026. Check wholesalers for inventory.

Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)


Clonazepam, Tablet, 1 mg (NDC 16729-137-16)


Not available. Long-term backorder for all NDCs. No estimated release date at this time.

Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09)


Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)


Clonazepam, Tablet, 2 mg (NDC 72888-154-30)


Endocrinology/Metabolism Gastroenterology Other Pediatric

Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31)


Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023

Minipress, Capsule, 1 mg (NDC 0069-4310-71)


Limited Supply Available. Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06)


Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Desipramine Hydrochloride, Tablet, 75 mg (NDC 23155-581-01)


INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS

Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)


Accupril, Tablet, 5 mg (NDC 0071-0527-23)


Dexamethasone Sodium Phosphate Injection

INTRA-ARTICULAR
INTRALESIONAL
INTRAMUSCULAR
INTRAVENOUS
SOFT TISSUE

Dermatology Endocrinology/Metabolism Gastroenterology Hematology Neurology Oncology Ophthalmology Other Pulmonary/Allergy Rheumatology

Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10)


Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Etravirine, Tablet, 100 mg (NDC 10147-0570-1)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)


Echothiophate Iodide Ophthalmic Solution

Available through limited distribution by Walgreens Specialty Pharmacy.

ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION

Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)


Technetium TC-99M Pyrophosphate Kit Injection

Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)


Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)


Fluvastatin Sodium Tablet, Extended Release

Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31)


Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)


Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)


Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30)


Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)


Guanfacine Hydrochloride Tablet, Extended Release

A business decision was made to discontinue manufacture of the drug.

Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)


This presentation is temporarily on backorder.

Analgesia/Addiction Gastroenterology Pediatric Pulmonary/Allergy

Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Next Delivery: June 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

EPIDURAL INFILTRATION INTRACAUDAL PERINEURAL

Adrenergic alpha-Agonists [MoA]
Adrenergic beta-Agonists [MoA]

alpha-Adrenergic Agonist [EPC]
beta-Adrenergic Agonist [EPC]
Catecholamine [EPC]

Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)


Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)


Unbranded Insulin Degludec 3 mL U-100 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Degludec, Injection, 3 mL Insulin Degludec 100 units/mL (U-100) FlexTouch® (NDC 73070-403-15)


Currently Inventory available 4 to 6 weeks as per current demand. Next supply: week of 02/09/2026

INTRA-ARTICULAR
INTRALESIONAL
INTRAMUSCULAR
INTRASYNOVIAL
SOFT TISSUE

Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)


609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)

Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.

Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95)

Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 68094-909-50)


Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99)


Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04)


Desipramine Hydrochloride, Tablet, 100 mg (NDC 23155-582-01)


Tazicef, Injection, 2 g (NDC 0409-5093-11)


LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE

ALANINE
ARGININE
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE HYDROCHLORIDE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)


Increased Diuresis at Loop of Henle [PE]

Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)

Requirements related to complying with good manufacturing practices


Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)


Discontinuation of the manufacture of the drug.

Pemetrexed Ditromethamine, Injection, 100 mg Single Dose Vial (NDC 0409-1060-01)


Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)


Product in transit, expected to arrive last week of April 2026

Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10)


Amlodipine Besylate; Benazepril Hydrochloride Capsule

Permanent discontinuation in the manufacturing of the drug

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

AMLODIPINE BESYLATE
BENAZEPRIL HYDROCHLORIDE


Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)


Inventory available 4 to 8 weeks as per current demand. Next supply: week of 2/23/2026

Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)


Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20)


Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)


Discontinuation of the manufacture of the drug

Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)


Albuterol 0.5% is in stock, though demand remains high; additional supply can be produced as needed.

Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)


Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)


Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)


Lisdexamfetamine Dimesylate Tablet, Chewable

Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)


Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95)


Lyumjev, Injection, U-100 Tempo Pen Sample (NDC 0002-8235-99)


Currently Inventory available 4 to 8 Weeks as per current demand. Next supply: week of 03/16/2026

Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1)


Mark Cuban Cost Plus Drug Company: 682-428-8081

Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)


Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95)


Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)


Pravastatin Sodium, Tablet, 40 mg (NDC 0093-7202-98)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 62135-242-60)


Next release May 2026. Check wholesalers for inventory.

Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)


Next Delivery: May 2026; Estimated Recovery: June 2026; Check Wholesaler for Availability; Shortage per Manufacturer: Manufacturing Delay

Endocrinology/Metabolism
Gastroenterology
Pediatric
Total Parenteral Nutrition

Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)


Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-32)


Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59)


Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)


Methylphenidate Hydrochloride Tablet, Extended Release

Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)


Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618

Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)


Pilocarpine Hydrochloride Ophthalmic Solution

Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: September 2026

Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)


Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)


Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)


Supply is expected to be depleted by 12/31/2025.

Parnate, Tablet, 10 mg (NDC 0591-5590-01)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32)


Euthyrox, Tablet, 175 ug (NDC 72305-175-30)


Cytochrome P450 3A4 Inhibitors [MoA]
Cytochrome P450 2C19 Inhibitors [MoA]
Cytochrome P450 2C9 Inhibitors [MoA]

Vfend, Injection, 10 mg/1 mL (NDC 0049-3190-01)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)


Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)


Dibenzyline, Capsule, 10 mg (NDC 59212-001-01)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)


Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)

Mylan Pharmaceuticals Inc., a Viatris Company


Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34)


844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)


Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 51224-206-50)


800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)


Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)


Riboflavin 5-phosphate  Ophthalmic Solution

Discontinuing manufacture of the product as of June 2026.

Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)


Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)


Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 25 mg; 40 mg (NDC 13668-385-90)


Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)


Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-32)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)


The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026.

Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]

Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]

Breast Cancer Resistance Protein Inhibitors [MoA]

Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]


Fresenius Medical Care Renal Therapies Group, LLC

Sodium Chloride 0.9% in Plastic Container, Injection, 900 mg/100 mL (NDC 49230-300-10)


Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0113-03)


Available. Distributed by Padagis US LLC

Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)


Potassium Chloride Tablet, Extended Release

Discontinuation of the manufacture of the drug product

Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-10)


Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270

Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC

Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)


Discontinuation of the manufacture of the drug.

Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)


Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)


Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

BUPIVACAINE HYDROCHLORIDE
EPINEPHRINE BITARTRATE

Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)


Clindamycin Palmitate Hydrochloride Injection

Discontinuation of the manufacture of the drug

CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)

Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)


LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE

DEXTROSE MONOHYDRATE
LIDOCAINE HYDROCHLORIDE ANHYDROUS

Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)


Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)


Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 50 mg (NDC 65862-063-59)


Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)


Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-13

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13)


Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)


Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60)


Additional lots will be available in the May 2026 timeframe.  Product will be made available as it is released.

Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)


Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10)


Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)


Wholesaler & Distributor through Marketing partner (Apotex Inc.)

Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)


Finasteride, Tablet, 5 mg (NDC 0093-7355-56)


Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)


Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com

Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07)


International Medication Systems, Limited

Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)


Currently Inventory available 2 to 4 Weeks as per current demand. Next supply: week of 02/09/2026

Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5)


Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-21)


Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)


Corticosteroid Hormone Receptor Agonists [MoA]

Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)


Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)


Clonazepam, Tablet, 2 mg (NDC 16729-138-16)


Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)


Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)


Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21)


Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)


Reyataz, Capsule, 200 mg (NDC 0003-3631-12)


Anti-Inflammatory Agents, Non-Steroidal [CS]

Nonsteroidal Anti-inflammatory Drug [EPC]

Celecoxib, Capsule, 50 mg (NDC 0591-3982-60)


Clonazepam, Tablet, .5 mg (NDC 0093-0832-01)


Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com

No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300

CROMOLYN SODIUM ORAL SOLUTION (CONCENTRATE)

Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)


Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 25 mg; 40 mg (NDC 13668-382-05)


On allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7120-07

DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)


Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 25 mg; 40 mg (NDC 13668-382-90)


Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)


Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)


Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96)


Slate Run Pharmaceuticals, LLC: 844-529-8988

Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988

Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)


Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)


Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-15)


Vidaza, Injection, 100 mg (NDC 59572-102-01)


Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)


Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)


Pravastatin Sodium, Tablet, 10 mg (NDC 0093-0771-10)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22)


Kinase Inhibitor [EPC]
mTOR Inhibitor Immunosuppressant [EPC]

Protein Kinase Inhibitors [MoA]
Cytochrome P450 3A4 Inhibitors [MoA]
Cytochrome P450 2D6 Inhibitors [MoA]
mTOR Inhibitors [MoA]

Everolimus, Tablet, 10 mg (NDC 0093-7769-24)


Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25)


Tracleer, Tablet, 125 mg (NDC 66215-102-03)


Intelence, Tablet, 100 mg (NDC 59676-570-01)


Aldactone, Tablet, 100 mg (NDC 0025-1031-31)


Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)


Clonazepam, Tablet, .5 mg (NDC 72888-152-01)


Next release June 2026. Check wholesalers for inventory.

Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)


Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)


The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE

Fresenius Medical Care de Mexico, S.A. de C.V.

CALCIUM CHLORIDE
DEXTROSE MONOHYDRATE
MAGNESIUM CHLORIDE
SODIUM CHLORIDE
SODIUM LACTATE

DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92)


845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com

Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90)


Calcium Chloride, Injection, 100 mg/1 mL (NDC 0409-4928-34)


Glucatrol XL, Tablet, Extended Release, 10 mg tablets; bottle of 500 (NDC 0049-0178-08)


Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)


BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)


Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)


Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)


Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)


Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)


INTRAMUSCULAR INTRAPLEURAL INTRAVENOUS SUBCUTANEOUS

Bleomycin Sulfate, Injection, 15 [USP'U] (NDC 0409-0332-20)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)


Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)


Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)


Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)


Bumetanide, Injection, .25 mg/1 mL (NDC 72205-101-07)


Discontinuation of the manufacture of the drug.

Rifampin, Capsule, 150 mg (NDC 42806-801-01)


Discontinuation of the manufacture of the drug

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Cytochrome P450 3A4 Inducers [MoA]
Cytochrome P450 1A2 Inducers [MoA]
Cytochrome P450 2B6 Inducers [MoA]
Cytochrome P450 2C9 Inducers [MoA]
Cytochrome P450 2C19 Inducers [MoA]


Acetaminophen; Oxycodone Hydrochloride Tablet

Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 10 mg (NDC 60951-712-70)


Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)


A business decision was made to discontinue manufacture of the product

Dietary Cholesterol Absorption Inhibitor [EPC]

Ezetimibe, Tablet, 10 mg (NDC 0591-3713-05)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)


Additional lots will be available in the May 2026 timeframe.  Product will be made available as it is released.

Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)


Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)


Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)


Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)


6, 7 & 9 month expiry available upon request. Check wholesaler for inventory

Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)


Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)


Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)


Ultiva, Injection, 5 mg (NDC 72078-036-05)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)


Meitheal Pharmaceuticals is distributor/labeler

Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)


Discontinuation of the manufacturing of the capsule presentation. 75 mg Tablet
NDC 0069-0284-03 will continue to be manufactured.

Kinase Inhibitors [MoA]
Cytochrome P450 3A Inhibitors [MoA]

Ibrance, Capsule, 75 mg (NDC 0069-0187-21)


Target availability: May 2026; Delay in shipping of the drug

Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01)


Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)


Additional lots will be available.  Product will be made available as it is released.

Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)


Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)


Clonazepam, Tablet, .5 mg (NDC 16729-136-16)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-106-10)


Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 1% 10X10ML) is Preservative free.

Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-003-10)


Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25)


See Related Information section below for customer service information

Marketed by Sandoz Inc.; Customer service: 800-525-8747

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)

Jiangsu Hengrui Pharmaceuticals Co., Ltd.


Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-4902-34)


Check wholesalers for inventory; Marketed by Fresenius Kabi

Etomidate, Injection, 2 mg/1 mL (NDC 65219-445-10)


Fluticasone Propionate; Salmeterol Xinafoate Powder

FLUTICASONE PROPIONATE
SALMETEROL XINAFOATE

AirDuo RespiClick, Powder, 113 ug; 14 ug (NDC 59310-812-06)


Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023

Minipress, Capsule, 5 mg (NDC 0069-4380-71)


Rifampin, Capsule, 300 mg (NDC 68180-659-07)


Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)


Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)


Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57)


Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)


Next release May 2026. Check wholesalers for inventory.

Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)


Reyataz, Capsule, 300 mg (NDC 0003-3622-12)


Eszopiclone, Tablet, 1 mg (NDC 0093-5537-56)


A business decision was made to discontinue manufacture of the drug.

Microzide, Capsule, 12.5 mg (NDC 0591-0347-05)


Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)


LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE

ALANINE
ARGININE
ASPARTIC ACID
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE

Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06)


Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension

Unbranded Insulin Aspart Protamine and Insulin Aspart Mix 70/30 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30

Insulin Aspart Protamine and Insulin Aspart Mix 70/30, Injectable Suspension, 10 mL Insulin aspart protamine and insulin aspart Mix 70/30 vial (NDC 73070-200-11)


Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay


Discontinuation of the manufacture of the drug product

Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-11)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-55

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)


Next release June 2026. Check wholesalers for inventory.

Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)


Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)


Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)


INTRALESIONAL
INTRAMUSCULAR
INTRASYNOVIAL
SOFT TISSUE

Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)


Check wholesalers for inventory; Marketed by Baxter

Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10)


Discontinuation of the manufacture of the drug.

Aldactone, Tablet, 25 mg (NDC 0025-1001-31)


Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug

Decitabine, Injection, 50 mg (NDC 68001-573-41)


INTRAMUSCULAR INTRATHECAL INTRAVENOUS SUBCUTANEOUS

Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25)


The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-209-94)


Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60)


Next Delivery and Estimated Recovery: TBD

Accupril, Tablet, 5 mg (NDC 0071-0527-23)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)


Discontinuation of the manufacture of the drug


Athenex is not active, supplying through Sagent NDC 25021-701-02

Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04)


Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)


Lisdexamfetamine Dimesylate Tablet, Chewable

Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

INTRALESIONAL
INTRAMUSCULAR
INTRASYNOVIAL
SOFT TISSUE
INTRA-ARTICULAR

Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)


Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)


Inventory available in vial presentations.

Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)


Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 1% 10X5ML)  is Preservative free.

Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-002-10)


This presentation is temporarily on backorder.

Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)


Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02)


Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1582-29)


Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)


Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 0406-1170-01)


Clonazepam, Tablet, 2 mg (NDC 0093-3213-05)


Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product

Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10)


Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE


Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)


Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24)


Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)


Estimated recovery: TBD; Shortage per Manufacturer: Manufacturing Delay

Demerol, Injection, 100 mg/1 mL (NDC 0409-1180-69)


Rifampin, Capsule, 300 mg (NDC 68180-659-06)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)


Technetium TC-99M Pyrophosphate Kit Injection

KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE

CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)


Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04)


Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)


Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1)


Next release May 2026. Check wholesalers for inventory.

Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)


Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 16729-081-01)


Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90)


A business decision was made to discontinue manufacture of the drug.

Angiotensin 2 Receptor Antagonists [MoA]

Valsartan, Tablet, 80 mg (NDC 0378-5813-77)


Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)


Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL) (NDC 0009-4073-04)


For orders, Solco Healthcare 866-931-9829

Clonazepam, Tablet, 1 mg (NDC 43547-407-10)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01)


Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24)


Product to expire in March 2026; Discontinuation of the manufacture of the drug

Nilandron, Tablet, 150 mg (NDC 59212-111-14)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03)


Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)


Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)


Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 25 mg (NDC 65862-062-01)


Fresenius Kabi, USA LLC
Fresenius Kabi USA, LLC

Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)


Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)


Hydrochlorothiazide; Quinapril Hydrochloride Tablet


Next release April 2026. Check wholesalers for inventory.

Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)


Microzide, Capsule, 12.5 mg (NDC 0591-0347-01)


Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)


Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)


Proton Pump Inhibitors [MoA]
Cytochrome P450 2C19 Inhibitors [MoA]

Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-92)


Potassium Citrate Tablet, Extended Release

A business decision was made to discontinue.

Potassium Citrate, Tablet, Extended Release, 5 meq (NDC 0591-2682-01)


Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30)


Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)


Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)


Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)


Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)


Tamiflu, Capsule, 45 mg (NDC 0004-0801-85)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: September 2026; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03)


Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)


Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23)


Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)


Discontinuation of the manufacture of the drug.

Desowen, Lotion, .5 mg/1 mL (NDC 0472-0803-04)


Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 25 mg; 40 mg (NDC 13668-385-30)


Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88)


Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10)


Discontinuation of the manufacture of the drug

Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)


Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)


Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25)


Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)


Euthyrox, Tablet, 100 ug (NDC 72305-100-30)


ENDOTRACHEAL INTRAMEDULLARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS

Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)


Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)


Vyvanse, Capsule, 30 mg (NDC 59417-103-10)


Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027

Pindolol, Tablet, 5 mg (NDC 57664-655-88)


Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

3, 4, 5, 7 & 8 month expiry available upon request. Check wholesaler for inventory

Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10)


Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)


Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)


Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)


Sodium Chloride 0.9%, Injection, 50 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-66)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)


Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)


Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30)


+82-2-854-4700 or via email intbiz@huons.com

Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2)


Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195

Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 81665-104-96)


On allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7918-19

DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19)


Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: March 2027; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)


Vyvanse, Capsule, 40 mg (NDC 59417-104-10)


Euthyrox, Tablet, 75 ug (NDC 72305-075-90)


Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08)


Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)


Nitroglycerin in Dextrose 5%, Injection, 10 mg/100 mL (NDC 0338-1047-02)


(201) 961-9000 or contact@risingpharma.com

Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 16571-600-96)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)


Rifampin, Capsule, 150 mg (NDC 42806-801-30)


Discontinuation of the manufacture of the drug. Manufactured for JG Pharma

Sulconazole Nitrate, Solution, 30 mL (NDC 72143-321-30)


Guanfacine Hydrochloride Tablet, Extended Release

A business decision was made to discontinue manufacture of the drug.

Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11)


Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)


Potassium Chloride Tablet, Extended Release

Discontinuation of the manufacture of the drug product

Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-15)


Desipramine Hydrochloride, Tablet, 10 mg (NDC 23155-578-01)


Hydrocortisone Sodium Succinate Injection

Pulmonary/Allergy Dermatology Endocrinology/Metabolism Gastroenterology Hematology Neurology Oncology Ophthalmology Pediatric Renal Rheumatology

Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03)


Next Delivery and Estimated Recovery: June 2027

Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)


Estimated recovery: TBD; Shortage per Manufacturer: Manufacturing Delay

Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01)


Vitamin D2 Analog [EPC]
Vitamin D Analog [EPC]

Zemplar, Capsule, 2 ug (NDC 0074-9037-30)


Additional lots will be available.  Product will be made available as it is released.

Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10)


Dexamethasone Sodium Phosphate Injection

Next release May 2026. Check wholesalers for inventory.

Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-20

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20)


Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)


(866) 850-2876 or CustomerService@AurobindoUSA.com

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)


Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)


Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)


Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)


LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE

Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)


Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10)


Clonazepam, Tablet, 1 mg (NDC 72888-153-30)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)


A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 12.5 mg; 40 mg (NDC 13668-386-05)


Limited Supply Available. Next Delivery and Estimated Recovery: June 2027

Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)


Discontinuation of the manufacture of the drug

Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11)


Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10)


Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)


Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)


Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7172-17

ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, AND GLYCINE

ACETYL L-TYROSINE
ALANINE
ARGININE
ASPARTIC ACID
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
THREONINE
TRYPTOPHAN
VALINE

Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17)


Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)


Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)


Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14)


ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE

ACETYL L-TYROSINE
ALANINE
ARGININE
ASPARTIC ACID
CYSTEINE HYDROCHLORIDE
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
TAURINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE

TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)


Pravastatin Sodium, Tablet, 10 mg (NDC 0093-0771-98)


Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)


Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)


Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 25 mg (NDC 65862-062-99)


LYSINE ACETATE, LEUCINE, PHENYLALANINE, VALINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, HISTIDINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, AND TYROSINE

Plenamine, Injection, 0.15 (NDC 0264-4500-05)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-03

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)


Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01)


Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74)


Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-32)


Celecoxib, Capsule, 400 mg (NDC 0591-3985-60)


Klonopin, Tablet, 2 mg (NDC 61269-620-10)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Next Delivery: May 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)


Lisdexamfetamine Dimesylate Tablet, Chewable

Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88)


Potassium Chloride Capsule, Extended Release

Potassium Chloride, Capsule, Extended Release, 750 mg (NDC 62037-560-10)


Granulocyte Colony-Stimulating Factor [CS]


Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)


Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25)


Basaglar, Injection, U-100 Tempo Pen (NDC 0002-8214-05)


Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)


Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-37

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37)


Unbranded Insulin Aspart 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Aspart, Injection, 10 mL Insulin Aspart vial (NDC 73070-100-11)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE


Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95)


Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023

Minipress, Capsule, 2 mg (NDC 0069-4370-71)


Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35)


Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)


Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)


Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)

Shortage of an inactive ingredient component


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 16729-081-10)


A business decision was made to discontinue manufacture of the drug.

Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60)


Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)


Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)


On backorder. Recovery: TBD. Check wholesalers for inventory

Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)


Athenex is not active, supplying through Sagent NDC  25021-700-01

Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02)


Vyvanse, Capsule, 60 mg (NDC 59417-106-10)


Otrexup, Injection, 25 mg/.4 mL (NDC 82497-025-04)


Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-05)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01)


Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)


Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)


Eszopiclone, Tablet, 2 mg (NDC 0093-5538-01)


Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 68094-909-30)


Nitroglycerin in Dextrose 5%, Injection, 40 mg/100 mL (NDC 0338-1051-02)


Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)


Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0409-1891-23)


Nitroglycerin, Injection, 5 mg/1 mL (NDC 0517-4810-25)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)


Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20)


Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)


A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.


Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-90)


Potassium Chloride, Capsule, Extended Release, 600 mg (NDC 62037-559-01)


Clonazepam, Tablet, 1 mg (NDC 72888-153-01)


Amlodipine Besylate; Benazepril Hydrochloride Capsule

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30)


Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.

Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)


Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)


732-382-6085 Monday to Friday 9 am to 3:45 pm

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01)


Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 5 MG,CLL

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 47781-174-01)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)


Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)


A business decision was made to discontinue manufacture of the product

Ezetimibe, Tablet, 10 mg (NDC 0591-3713-30)


Methylphenidate Hydrochloride Tablet, Extended Release

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)


Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-01)


Dibenzyline, Capsule, 10 mg (NDC 59212-001-02)


Marketed by Sandoz Inc.; Customer service: 800-525-8747

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL  (NDC 0781-3494-95)


Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)


Anti-epileptic Agent [EPC]
Mood Stabilizer [EPC]

Organic Cation Transporter 2 Inhibitors [MoA]

Dihydrofolate Reductase Inhibitors [MoA]

Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 64850-300-01)


Crinone, Vaginal Gel, 4% (NDC 0023-6150-04)


Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)


Discontinuation of the manufacture of the drug product

Amantadine Hydrochloride, Tablet, 100 mg (NDC 0832-0111-50)


Clonazepam, Tablet, .5 mg (NDC 43547-406-11)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-23

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23)


Discontinuation of the manufacture of the drug

Euthyrox, Tablet, 125 ug (NDC 72305-125-90)


Lots are being manufactured to meet demand

Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)


Permanent discontinuation of specific package size/ SKU for business reasons.

Nortriptyline Hydrochloride, Capsule, 75 mg (NDC 0093-0813-05)


Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10)


Clonazepam, Tablet, .5 mg (NDC 59651-722-99)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 12.5 mg; 40 mg (NDC 13668-383-30)


Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)


Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)


Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)


Euthyrox, Tablet, 137 ug (NDC 72305-137-30)


Estimated recovery: TBD; check wholesalers for inventory

Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88)


Permanent discontinuation of manufacture due to business decision.

Minocycline Hydrochloride, Capsule, 75 mg (NDC 0591-3153-01)


Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)


Not available. Long-term backorder for all NDCs. No estimated release date at this time.

Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09)


Permanent discontinuation in the manufacturing of the drug

Lotrel, Capsule, 5 mg; 10 mg (NDC 0078-0405-05)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 12.5 mg; 20 mg (NDC 13668-397-05)


Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25)


Euthyrox, Tablet, 200 ug (NDC 72305-200-90)


Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)


Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)


Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01)


Next Delivery and Estimated Recovery: TBD

Accupril, Tablet, 10 mg (NDC 0071-0530-23)


Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9)


Nitroglycerin in Dextrose 5%, Injection, 20 mg/100 mL (NDC 0338-1049-02)


Potassium Chloride Tablet, Extended Release

Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)


Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48)


Vancomycin Hydrochloride, Injection, 750 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-6531-01)


Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)


Currently product is under backorder as per current demand. Next supply: week of 02/09/2026

Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5)


Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)


Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)


Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)


Euthyrox, Tablet, 88 ug (NDC 72305-088-30)


Discontinuation of the manufacturer of the drug

Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86)


Pegasys availability will become more limited through Q4 2025. Product replenishment is expected sometime in 2026 and before May 31, 2026.

Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)


Tobramycin, Solution, 300 mg/4 mL (NDC 0093-3750-63)


Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20)


Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1)


Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)


Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)


Pilocarpine Hydrochloride Ophthalmic Solution

Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88)


Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02)


Sporanox, Capsule, 100 mg (NDC 50458-290-04)


Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 15 MG,CLL

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 47781-178-01)


Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14)


Celecoxib, Capsule, 100 mg (NDC 0591-3983-01)


Everolimus, Tablet, 5 mg (NDC 49884-125-91)


Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30)


Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)


Lisdexamfetamine Dimesylate Tablet, Chewable

Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)


Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)


Discontinuation of the manufacture of the drug.

SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)


INTRA-ARTERIAL
INTRALESIONAL
INTRAMUSCULAR
SOFT TISSUE

Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)


Next release not available at this time. Check wholesalers for inventory.

Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)


Everolimus, Tablet, 3 mg (NDC 0378-0006-85)


Fluvastatin Sodium Tablet, Extended Release

Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31)


Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)


Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)


Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-05)


Check wholesalers for inventory; Marketed by Baxter

Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10)


Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)


DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)


Discontinuation of the manufacture of the drug product

Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-10)


Next Delivery: May 2026; Estimated Recovery: September 2026

Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)


Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18)


Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01)


Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)


A business decision was made to discontinue manufacture of the drug.

Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)


EPINEPHRINE BITARTRATE
LIDOCAINE HYDROCHLORIDE ANHYDROUS

Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)


Discontinuation of the manufacture of the drug

Tobramycin, Solution, 300 mg/5 mL (NDC 0093-4085-63)


Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)"


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20)


Euthyrox, Tablet, 88 ug (NDC 72305-088-90)


Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)


This presentation is temporarily on backorder.

Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)


Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-11)


Wholesaler & Distributor through Marketing partner (Apotex Inc.)

Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25)


Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)


Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)


Otrexup, Injection, 15 mg/.4 mL (NDC 82497-015-04)


Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01)


Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)


Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7139-36

Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36)


Acetaminophen; Oxycodone Hydrochloride Tablet

Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 7.5 mg (NDC 60951-700-70)


Next release May 2026. Check wholesalers for inventory.

Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)


Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)


Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)


Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11)


Available. Distributed by Padagis US LLC

Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 0406-1170-03)


Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-05)


Business decision. Products will not be available after November 14, 2025.

Ocaliva, Tablet, 10 mg (NDC 69516-010-30)


Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)


Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug

Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)


Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)


Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05)


Product to expire in March 2026; Discontinuation of the manufacture of the drug

Nilandron, Tablet, 150 mg (NDC 66993-212-38)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10)


Clonazepam, Tablet, 1 mg (NDC 43547-407-50)


Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)


Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)


Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)


The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.

Chemokine Co-receptor 5 Antagonists [MoA]

Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton  (NDC 49702-260-55)


SODIUM ACETATE INJECTION, USP, 400 MEQ/100 ML

Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41)


Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)


Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)


Everolimus, Tablet, 2 mg (NDC 0378-0005-85)


Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)


Tamarang is the application holder and X-Gen is the distributor/labeler

Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)


Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10)


Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)


Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)


Sporanox, Capsule, 100 mg (NDC 50458-290-01)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)


Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)


Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2)  (NDC 0409-4911-34)"


Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)


ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7171-17

ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, AND GLYCINE

Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17)


Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)


Methylin Er, Tablet, Extended Release, 20 mg (NDC 0406-1473-01)


Discontinuation of the manufacture of the drug. Product expected to be available through July 2026.

Synagis, Injection, 100 mg/1 mL (NDC 66658-231-01)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)


Azacitidine, Injection, 100 mg (NDC 72485-201-01)


Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76)


Euthyrox, Tablet, 100 ug (NDC 72305-100-90)


Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)


Analgesia/Addiction Gastroenterology Other Pulmonary/Allergy

Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)


Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)


Zithromax, Tablet, 500 mg (NDC 0069-3070-30)


Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37)


Euthyrox, Tablet, 25 ug (NDC 72305-025-90)


Methylin Er, Tablet, Extended Release, 36 mg (NDC 0406-0136-01)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)


Decreased Sebaceous Gland Activity [PE]
Neuromuscular Blockade [PE]

Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)


Gemcitabine Hydrochloride, Injection, 200 mg/5.26 mL (38 mg/mL), sterile solution in a single-dose glass vial NovaPlus (NDC 0409-0183-25)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 100 mg (NDC 65862-064-99)


Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)


Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586

Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)


Athenex is not active, supplying through Sagent NDC 25021-701-01

Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-03)


Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)


Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)


Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)


Discontinuation of the manufacture of the drug

Sodium Chloride 0.9% in Plastic Container, Injection, 900 mg/100 mL (NDC 46163-300-10)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31)


Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)


Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)


Discontinuation of the manufacturer of the drug

Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30)


Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30)


Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)


Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)


A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 12.5 mg; 40 mg (NDC 13668-383-05)


Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)


Discontinuation in the manufacturing of the drug


Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)


Pravastatin Sodium, Tablet, 20 mg (NDC 0093-7201-98)


Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)


Euthyrox, Tablet, 175 ug (NDC 72305-175-90)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)


Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)


Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)


Clindamycin Phosphate; Benzoyl Peroxide Gel

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Clindamycin Phosphate; Benzoyl Peroxide, Gel, 25 mg/1 g; 10 mg/1 g (NDC 0591-3916-68)


Glyburide (Micronized), Tablet, 3 mg (NDC 0093-8035-05)


Product not anticipated to be available beyond mid-late September 2025

Irinotecan Hydrochloride, Injection, 20 mg/1 mL (NDC 45963-614-55)


Methylphenidate Hydrochloride Tablet, Extended Release

Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)


Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46)


Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)


Discontinuation of the manufacture of the drug.

Ferriprox, Tablet, 500 mg (NDC 10122-100-10)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3)


Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)


Next Delivery and Estimated Recovery: June 2026

Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)


Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10)


Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)


Company Contact: 609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)

Discontinuation of the manufacture of the drug; Distributed by Sagent Pharmaceuticals

Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 25021-230-02)


Meitheal Pharmaceuticals is distributor/labeler

Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)


Product temporarily on backorder.  Additional lots will be available in the May timeframe.

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)


Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)


Fluphenazine Hydrochloride, Tablet, 2.5 mg (NDC 0832-6004-11)


Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)

EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)


Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)


EPIDURAL INTRACAUDAL PERINEURAL INFILTRATION

Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31)


Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)


Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)


Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)


Dexamethasone Sodium Phosphate Injection

Product will be made available as it is released.

Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)


Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-36

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)


Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)


Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)


Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20)


Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10)


Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug

Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01)


Clonazepam, Tablet, .5 mg (NDC 72888-152-05)


Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1)


Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)


Otrexup, Injection, 22.5 mg/.4 mL (NDC 82497-022-04)


Next release May 2026. Check wholesalers for inventory.

Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)


Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

Low supply of Amphetamine combo 30mg due to packaging delays

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)


Discontinuation of the manufacture of the drug

Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-01)


Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-10)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 12.5 mg; 40 mg (NDC 13668-386-90)


Product temporarily on backorder.  Additional lots will be available in the May 2026 timeframe.

Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20)


Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50)


Limited Supply Available. Next Delivery and Estimated Recovery: December 2028

Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)


A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 25 mg; 40 mg (NDC 13668-382-30)


Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)


Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)


Clonazepam, Tablet, 1 mg (NDC 59651-723-01)


Distributed by Avenacy; Contact information: 877-283-6229

Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)


Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09)


Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-31)


Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)


Check wholesalers for inventory; Marketed by Fresenius Kabi

Etomidate, Injection, 40 mg/20 mL (NDC 65219-445-20)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)


Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)


Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)


Next release not available at this time. Check wholesalers for inventory.

Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)


Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)


Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)


Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)


Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82)


Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24)


Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14)


A business decision was made to discontinue manufacture of the drug.

Valsartan, Tablet, 320 mg (NDC 0378-5815-77)


Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)


Discontinuation of the manufacture of the drug.

Fluphenazine Hydrochloride, Tablet, 1 mg (NDC 0832-6003-11)


Clonazepam, Tablet, .5 mg (NDC 16729-136-00)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7938-19

Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19)


Doxylamine Succinate and Pyridoxine  Hydrochloride Tablet, Delayed Release

DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

DOXYLAMINE SUCCINATE
PYRIDOXINE HYDROCHLORIDE

Doxylamine Succinate and Pyridoxine  Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)


Additional product will be made available as it is released.

Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01)


Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-30)


SODIUM ACETATE INJECTION, USP, 200 MEQ/100 ML

Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)


Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)


Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11)


Discontinuation of the manufacture of the drug product

Amantadine Hydrochloride, Tablet, 100 mg (NDC 0832-0111-00)


Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.

Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)


Vyvanse, Capsule, 10 mg (NDC 59417-101-10)


Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)


Ultiva, Injection, 2 mg (NDC 72078-035-02)


Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)


Lisdexamfetamine Dimesylate Tablet, Chewable

Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)


Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)


Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)


Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)


SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02)


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35)


Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)


Product not anticipated to be available beyond mid-late October 2025

Irinotecan Hydrochloride, Injection, 20 mg/1 mL (NDC 45963-614-51)


Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)


Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25)


Potassium Chloride Tablet, Extended Release

Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-11)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01)


Discontinuation is for the “NovaPlus” label product only.

Amide Local Anesthetic [EPC]
Antiarrhythmic [EPC]


Discontinuation of the manufacture of the drug

Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)


Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92)


Adefovir Dipivoxil, Tablet, 10 mg (NDC 60505-3947-3)


Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)


Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41)


Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)


Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20)


Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-10)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)


Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay


Tamarang is the application holder and X-Gen is the distributor/labeler

Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)


Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)


Pilocarpine Hydrochloride Ophthalmic Solution

Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05)


Meitheal Pharmaceuticals is distributor/labeler

Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)


Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)


Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)


Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)


Next Delivery and Estimated Recovery: TBD


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)


Celecoxib, Capsule, 100 mg (NDC 0591-3983-05)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 30 MG,CLL

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 47781-180-01)


Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)


Potassium Citrate Tablet, Extended Release

A business decision was made to discontinue.

Potassium Citrate, Tablet, Extended Release, 10 meq (NDC 0591-2729-01)


Additional lots will be available.  Product will be made available as it is released.

Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)


Celecoxib, Capsule, 200 mg (NDC 0591-3984-01)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01)


Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)


Fluvastatin Sodium Tablet, Extended Release

Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026

Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)


Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)


Zithromax, Tablet, 250 mg (NDC 0069-4061-01)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7930-09

Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10)


Unbranded Insulin Aspart 3 mL PenFill® cartridge will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Aspart, Injection, 3 mL Insulin Aspart PenFill® cartridge (NDC 73070-102-15)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 1% 10X2ML) is Preservative free.

Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-001-10)


Methylphenidate Hydrochloride Tablet, Extended Release

Methylin Er, Tablet, Extended Release, 10 mg (NDC 0406-1445-01)


Next release May 2026. Check wholesalers for inventory.

Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)


Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-01)


Potassium Chloride Capsule, Extended Release

Potassium Chloride, Capsule, Extended Release, 750 mg (NDC 62037-560-05)


Discontinuation of the manufacture of the drug.

Rifampin, Capsule, 300 mg (NDC 42806-799-01)


Azacitidine, Injection, 100 mg (NDC 43598-305-62)


Clindamycin Palmitate Hydrochloride Injection

Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)


Desipramine Hydrochloride, Tablet, 150 mg (NDC 23155-583-25)


Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74)


A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 12.5 mg; 20 mg (NDC 13668-397-30)


Unbranded Insulin Degludec 3 mL U-200 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Degludec, Injection, 3 mL Insulin Degludec 200 units/mL (U-200) FlexTouch® (NDC 73070-503-15)


A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.


Acetaminophen; Oxycodone Hydrochloride Tablet

Discontinuation of the manufacture of the drug

Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-70)


Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)


Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)


Fluticasone Propionate; Salmeterol Xinafoate Powder

AirDuo RespiClick, Powder, 55 ug; 14 ug (NDC 59310-805-06)


Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)


Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34)


Ampicillin Sodium, Injection, 10 g (NDC 0781-9409-95)


Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02)


Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)


A business decision was made to discontinue manufacture of the drug.

Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01)


Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)


Potassium Citrate, Tablet, Extended Release, 15 meq (NDC 0591-2742-01)


Accuretic, Tablet, 25 mg/20 mg (NDC 0071-0223-23)


Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)


Discontinuation in the manufacturing of the drug


Next Delivery: June 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)


Rifampin, Capsule, 300 mg (NDC 42806-799-30)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01)


This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately February 28, 2026.

Serotonin 1b Receptor Agonists [MoA]
Serotonin 1d Receptor Agonists [MoA]

Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Imitrex, Nasal Spray, 5 mg/100 uL (NDC 66993-081-69)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE


Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)


LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE

ALANINE
ARGININE
ASPARTIC ACID
CYSTEINE HYDROCHLORIDE
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
TAURINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE

Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03)


Please check wholesalers and distributors for inventory.

Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)


Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)


Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)


Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)


Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)


Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01)


Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 100 mg (NDC 65862-064-39)


Bleomycin Sulfate, Injection, 30 [USP'U] (NDC 0409-0323-20)


Methylin Er, Tablet, Extended Release, 27 mg (NDC 0406-0127-01)


Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)


Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)


No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2

Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96)


Tazicef, Injection, 1 g (NDC 0409-5092-16)


Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17)


Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91)


Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-05)


Product is expected to be available through June 2027.

Rozerem, Tablet, 8 mg (NDC 64764-805-30)


Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)


Hikma has permanently discontinued (NDC 0054-0390-41) for the 15 mL bottle configuration. Hikma will continue to distribute Oxycodone Hydrochloride Oral Solution 5 mg/5 mL in the 500 mL bottle (NDC 0054-0390-63).

Oxycodone Hydrochloride, Oral Solution, 5 mg/5 mL (NDC 0054-0390-41)


Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)


Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)


Next Delivery: May 2026; Estimated Recovery: September 2026

Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)


Sodium Chloride 0.9%, Injection, 100 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-67)


Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)


The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE

DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 46163-212-94)


Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)